VEGFR-2 as a novel predictor of survival in gastric cancer: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

VEGFR-2 as a novel predictor of survival in gastric cancer: A systematic review and meta-analysis

Published:2018-04 Issue:4 Volume:214 Page:560-564
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Li Teng,Yu Jing,Luo Xinyu,Ren Weiguo,Zhang Yue,Cao Bangwei

Funder

Beijing Municipal Natural Science Foundation

Beijing traditional Chinese medicine science and Technology Development Fund Project

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference21 articles.

1. Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis;Jing;J. Hematol. Oncol.,2016

2. Short and long-term survival from gastric cancer: a population-based study from a county hospital during 25 years;Lello;Acta Oncol.,2007

3. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized double-blind placebo-controlled phase III study;Ohtsu;J Clin. Oncol.,2011

4. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial;Fuchs;Lancet,2014

5. Randomized, double-Blind, placebo-controlled phase III trial of Apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction;Li;J. Clin. Oncol.,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the anticancer properties of a new nicotinamide analogue: Investigations into in silico analysis, antiproliferative effects, selectivity, VEGFR-2 inhibition, apoptosis induction, and migration suppression;Pathology - Research and Practice;2023-12

2. An Overview of Current Biomarkers, the Therapeutic Implications, and the Emerging Role of hERG1 Expression in Gastric Cancer: A Literature Review;Cureus;2023-10-23

3. Discovery of novel VEGFR-2-PROTAC degraders based on the localization of lysine residues via recruiting VHL for the treatment of gastric cancer;European Journal of Medicinal Chemistry;2022-12

4. Licoflavone A Suppresses Gastric Cancer Growth and Metastasis by Blocking the VEGFR-2 Signaling Pathway;Journal of Oncology;2022-04-25

5. Discovery of Novel VEGFR-2-PROTAC Degraders Based on the Localization of Lysine Residues via Recruiting VHL for the Treatment of Gastric Cancer;SSRN Electronic Journal;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3